Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 292

1.

Racial and ethnic disparities in meeting Part D MTM eligibility criteria among the non-Medicare population.

Wang J, Brown LM, Hong SH.

J Am Pharm Assoc (2003). 2012 Sep-Oct;52(5):e87-96.

2.

Racial and ethnic disparities in meeting MTM eligibility criteria among patients with asthma.

Lu D, Qiao Y, Johnson KC, Wang J.

J Asthma. 2017 Jun;54(5):504-513. doi: 10.1080/02770903.2016.1238927. Epub 2016 Sep 27.

PMID:
27676212
3.

Historical trend of racial and ethnic disparities in meeting Medicare medication therapy management eligibility in non-Medicare population.

Wang J, Zhang Z, Spivey CA, Chisholm-Burns M.

Res Social Adm Pharm. 2014 Nov-Dec;10(6):904-17. doi: 10.1016/j.sapharm.2014.02.007. Epub 2014 Mar 2.

4.

Potential health implications of racial and ethnic disparities in meeting MTM eligibility criteria.

Wang J, Qiao Y, Tina Shih YC, Wan JY, White-Means SI, Dagogo-Jack S, Cushman WC.

Res Social Adm Pharm. 2014 Jan-Feb;10(1):106-25. doi: 10.1016/j.sapharm.2013.03.007. Epub 2013 Jun 10.

5.

Potential Health Implications of Medication Therapy Management Eligibility Criteria in the Patient Protection and Affordable Care Act Across Racial and Ethnic Groups.

Wang J, Qiao Y, Shih YC, Jarrett-Jamison J, Spivey CA, Wan JY, White-Means SI, Dagogo-Jack S, Cushman WC, Chisholm-Burns M.

J Manag Care Spec Pharm. 2015 Nov;21(11):993-1003.

6.

Historical trend of disparity implications of Medicare MTM eligibility criteria.

Wang J, Qiao Y.

Res Social Adm Pharm. 2013 Nov-Dec;9(6):758-69. doi: 10.1016/j.sapharm.2012.09.003. Epub 2012 Oct 10.

7.

Disparity implications of Medicare eligibility criteria for medication therapy management services.

Wang J, Mullins CD, Brown LM, Shih YC, Dagogo-Jack S, Hong SH, Cushman WC.

Health Serv Res. 2010 Aug;45(4):1061-82. doi: 10.1111/j.1475-6773.2010.01118.x. Epub 2010 May 24.

8.

Disparity Implications of Proposed 2015 Medicare Eligibility Criteria for Medication Therapy Management Services.

Wang J, Qiao Y, Spivey CA, Li C, Clark C, Deng Y, Liu F, Tillman J, Chisholm-Burns M.

J Pharm Health Serv Res. 2016 Dec;7(4):209-215. doi: 10.1111/jphs.12142. Epub 2016 May 26.

9.

Effects of medicare part d on disparity implications of medication therapy management eligibility criteria.

Wang J, Qiao Y, Shih YC, Jamison JJ, Spivey CA, Li L, Wan JY, White-Means SI, Dagogo-Jack S, Cushman WC, Chisholm-Burns M.

Am Health Drug Benefits. 2014 Sep;7(6):346-58.

10.

Has Medicare Part D reduced racial/ethnic disparities in prescription drug use and spending?

Mahmoudi E, Jensen GA.

Health Serv Res. 2014 Apr;49(2):502-25. doi: 10.1111/1475-6773.12099. Epub 2013 Sep 18.

11.

Potential effects of racial and ethnic disparities in meeting Medicare medication therapy management eligibility criteria.

Wang J, Qiao Y, Tina Shih YC, Spivey CA, Dagogo-Jack S, Wan JY, White-Means SI, Cushman WC, Chisholm-Burns MA.

J Pharm Health Serv Res. 2014 Jun;5(2):109-118.

12.

Racial/ethnic disparities in Medicare Part D experiences.

Haviland AM, Elliott MN, Weech-Maldonado R, Hambarsoomian K, Orr N, Hays RD.

Med Care. 2012 Nov;50 Suppl:S40-7. doi: 10.1097/MLR.0b013e3182610aa5.

13.

How Did Medicare Part D Affect Racial and Ethnic Disparities in Drug Coverage?

Mahmoudi E, Levy HG.

J Gerontol B Psychol Sci Soc Sci. 2016 May;71(3):581-9. doi: 10.1093/geronb/gbu170. Epub 2014 Dec 22.

PMID:
25533317
14.

Racial and ethnic differences in outcomes in older patients with acute ischemic stroke.

Qian F, Fonarow GC, Smith EE, Xian Y, Pan W, Hannan EL, Shaw BA, Glance LG, Peterson ED, Eapen ZJ, Hernandez AF, Schwamm LH, Bhatt DL.

Circ Cardiovasc Qual Outcomes. 2013 May 1;6(3):284-92. doi: 10.1161/CIRCOUTCOMES.113.000211. Epub 2013 May 16.

15.

Racial and Ethnic Disparities in Diabetes Screening Between Asian Americans and Other Adults: BRFSS 2012-2014.

Tung EL, Baig AA, Huang ES, Laiteerapong N, Chua KP.

J Gen Intern Med. 2017 Apr;32(4):423-429. doi: 10.1007/s11606-016-3913-x. Epub 2016 Nov 15.

PMID:
27848187
16.

Effects of Medicare Part D on Racial/Ethnic Disparities in Hospital Utilization Among Seniors.

Mahmoudi E, Jensen GA, Tarraf W.

J Aging Health. 2015 Aug;27(5):797-826. doi: 10.1177/0898264315569450. Epub 2015 Feb 9.

PMID:
25670007
17.

Racial/Ethnic Differences in Cost-Related Nonadherence and Medicare Part D: A Longitudinal Comparison.

Bakk L.

J Health Care Poor Underserved. 2015 Nov;26(4):1132-48. doi: 10.1353/hpu.2015.0113.

PMID:
26548668
18.

Evaluation of Eligibility Criteria Used to Identify Patients for Medication Therapy Management Services: A Retrospective Cohort Study in a Medicare Advantage Part D Population.

Lee JS, Yang J, Stockl KM, Lew H, Solow BK.

J Manag Care Spec Pharm. 2016 Jan;22(1):22-30. doi: 10.18553/jmcp.2016.22.1.22.

19.

Racial and ethnic disparities in healthcare-associated infections in the United States, 2009-2011.

Bakullari A, Metersky ML, Wang Y, Eldridge N, Eckenrode S, Pandolfi MM, Jaser L, Galusha D, Moy E.

Infect Control Hosp Epidemiol. 2014 Oct;35 Suppl 3:S10-6. doi: 10.1086/677827.

PMID:
25222888
20.

Racial/ethnic differences in obesity and comorbidities between safety-net- and non safety-net integrated health systems.

Balasubramanian BA, Garcia MP, Corley DA, Doubeni CA, Haas JS, Kamineni A, Quinn VP, Wernli K, Zheng Y, Skinner CS.

Medicine (Baltimore). 2017 Mar;96(11):e6326. doi: 10.1097/MD.0000000000006326.

Supplemental Content

Support Center